This page is an unofficial mirror and is not legal advice. Verify the document against the official source before relying on it.
HB1638: creating a bypass mechanism for health insurer step therapy protocols when medically necessary.
Bill details
No mirrored bill text is available for this bill yet. Use the official source links below for the full current record.
Last sync warning: curl exited 52: curl: (52) Empty reply from server
Version history, amendments, and roll-call votes were not present in the imported local bill data.
Official links
Extraction diagnostics
Related law links
RSA references from bill data
-
420-J
· amend
ep therapy protocols when medically necessary. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Step Therapy. Amend RSA 420-J by inserting after section 26 the following new subdivision: Step Therapy 420-J:27 Definitions. As used in this subdivision: I. "Advanced, metastatic cancer" means a cancer that has spread from the primary or orig
-
420-J:28
· add
ce, research and newly developed treatments. 420-J:29 Absence of Clinical Practice Guidelines. In the absence of clinical practice guidelines that satisfy the requirements under RSA 420-J:28, peer-reviewed publications may be used as a substitute. 420-J:30 Consideration of Atypical Populations and Diagnoses. When establishing a step therapy protocol, a utilization review organization shall also take into
-
541-A
· reference
y peer-reviewed, evidence-based literature; and III. Approved by the United States Food and Drug Administration. 420-J:34 Rules. The commissioner may adopt rules, pursuant to RSA 541-A, to assist the insurance department with the implement this section. 2 Effective Date. This act shall take effect 90 days after its passage. LBA 26-3029 12/2/25 HB 1638-FN- FISCAL NOTE AS INTRODUCED